Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.

Atherosclerosis - 1 Dec 2003

Caslake Muriel J, Stewart Grace, Day Stephen P, Daly Elaine, McTaggart Fergus, Chapman M John, Durrington Paul, Laggner Peter, Mackness Michael, Pears John, Packard Chris J

Abstract excerpt

This randomised, double-blind, placebo-controlled crossover study evaluated the effects of rosuvastatin (40 mg/day for 8 weeks) on atherogenic apolipoprotein B-containing lipoprotein subfractions. Subjects, recruited based on raised plasma triglyceride (TG) or low-density lipoprotein cholesterol (LDL-C), were divided into normotriglyceridaemic (NTG, n = 13; TG < 2.0 mmol/l) and hypertriglyceridaemic (HTG, n = 16;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Apolipoproteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Over Studies

Share to Drug Administration Schedule

Share to Hyperlipidemias

Share to Lipoproteins, LDL

Share to Lipoproteins, VLDL

Share to Rosuvastatin Calcium

Source

Identifiers

PMID: 14644393
DOI: 10.1016/j.atherosclerosis.2003.08.025

Genes

CETP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.PMID 14644393Read ↗

Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.Semantic proximity Read ↗

Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures.Semantic proximity Read ↗

Phenotypes, genotypes and response to statin therapy.Semantic proximity Read ↗

Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.Semantic proximity Read ↗

Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP.Semantic proximity Read ↗

Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults.Semantic proximity Read ↗

Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.Semantic proximity Read ↗

Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.Semantic proximity Read ↗

The association of circulating microRNA-30c with atherogenic lipoprotein subfractions and composition.Semantic proximity Read ↗

Atherogenic lipoprotein phenotype and diet-gene interactions.Semantic proximity Read ↗

Do triglyceride-lowering drugs decrease risk of cardiovascular disease?Semantic proximity Read ↗

Pharmacogenetic determinants of statin-induced reductions in C-reactive protein.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.